|
Market Cap (17-May) $614,874,944 (281st) |
Close (30-Jun) $3.44 |
Volume (30-Jun) 301,613 |
Shortsold (5-May) 5,242,611 (2.64%) (96th) |
|
52w High $3.81 |
52w Low $2.06 |
P/E 14.73 |
EPS 0.15 |
ACL released this announcement to the ASX on 22 November 2022, 16:57. The announcement is not marked as price sensitive, and is 2 page(s) in length and 85.6kb in size.
You can view all announcements from ACL and see how they appear on a price chart on the announcements page.
At the date of this announcement, ACL was 4.254% short sold according to ASIC data. It was ranked the 54th most shorted stock on the ASX. It remains ranked 96th as of the latest reported data (05 May 2025).
| Other Recent Announcements from ACL | |
|---|---|
| HLS: Directors' Statement re Takeover | 23 May 2023, 9:09 |
| Response to Healius' Target's Statement | 22 May 2023, 9:55 |
| Second Supplementary Bidder's Statement | 22 May 2023, 9:41 |
| Ceasing to be a substantial holder | 22 November 2022, 16:57 |
| Becoming a substantial holder | 11 November 2022, 17:05 |
| Medlab Pathology Cyber Incident | 27 October 2022, 8:15 |
| 2022 AGM - Results of Meeting | 19 October 2022, 11:32 |
You must be logged in to post a reply.
